Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Omalizumab

Brand: Xolair®
NICE TA: 278
Indication: Treatment of severe persistent allergic asthma - review of TA133 & 210 (NICE TA 278)
Disease category: Respiratory system
Commissioning responsibility: NHS England
PbR excluded: Yes

Background

Patient access scheme
LMMG is adopting the local decision made prior to April 2013

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red

Red